News + Resources
New NAM Report Finds Biopharmaceutical R&D Investment Crucial for Patients, the Economy
Thousands of life sciences companies from across the U.S. compete every day to bring the next generation of treatments and cures to market. Within this ecosystem, pharmaceutical manufacturers play a key role in developing new therapies and cures. By mobilizing their...
PULSE Statement on Finalized Joint Merger Guidelines from FTC, DOJ
Latest guidance could pose unintended consequences for life science ecosystem, pro-innovation M&A Washington, D.C. – In response to the latest merger guidelines released today by the Federal Trade Commission (FTC) and Department of Justice (DOJ), the Partnership...
Opinion: Proposed regulation would limit life-saving research in Ohio
Ohio has had incredible success in the life sciences in recent years. The first-ever novel gene therapy brain infusion for Parkinson’s disease was developed here, along with the first-ever gene therapy treatment for Duchenne’s muscular dystrophy. Add state-of-the-art...
In Case You Missed It: PULSE Webinar – Life Science M&A: Supporting the Next Generation of Biopharma Breakthroughs
To view the full event recording, click here. Across the life sciences industry, companies engage in a constant “relay race” to bring new and groundbreaking treatments to market. The critical partnerships and “hand-offs” between companies of all sizes are core...
The Legislative Pillars Supporting Innovation & Access in the Life Sciences Ecosystem
For nearly four decades, policymakers have prioritized bipartisan policies that incentivize investment in groundbreaking medical research – aiming to make new innovations accessible for millions of Americans.